NCT04847388View on ClinicalTrials.gov

Prevalence of Substance Abuse Among Anti-retroviral Treatment Naive Patients Positive for HIV Antibodies

CompletedOBSERVATIONAL

Enrollment

210

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

March 15, 2022

Study Completion Date

March 15, 2022

Conditions

HIV Infections

Interventions

DRUG

Substance like alcohol, marijuana, etc.

Cohort study

Trial Locations (1)

851204

ART centre, Sadar Hospital, Khagaria

All Listed Sponsors

lead

Singh, Ranjan Kumar, M.D.

INDIV

NCT04847388 - Prevalence of Substance Abuse Among Anti-retroviral Treatment Naive Patients Positive for HIV Antibodies | Biotech Hunter | Biotech Hunter